GUIDELINES ON COMPANY PROCEDURES RELATING TO THE 2021 ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY 

Published 7 July 2021

Please click here for more details

The Prescription Medicines Code of Practice Authority

The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, independently of the ABPI.  It was established by the ABPI on 1 January 1993.

The Authority is responsible for the provision of advice, guidance and training on the Code as well as for the complaints procedure.  It is also responsible for arranging for conciliation between companies when requested to do so and for arranging for the scrutiny of advertising and meetings on a regular basis.

 

TRAINING 

Code of Practice Seminars 

- dates under review due to COVID-19

ABPI Examination for Medical Representatives

More information is available on the ABPI website, link below

https://exams.abpi.org.uk/Pages/home.aspx

To extend the time available to take the examination an application for an extension should be made on the form on this website, link below  

https://www.pmcpa.org.uk/training/application-for-an-extension-of-time-to-take-the-representative-examinations/

The extension request should preferably be made by the company rather than the representative. 

In house training 

- under review due to COVID-19

For more information see Training Opportunities. 

https://www.pmcpa.org.uk/training/

Media

  • LEO Pharma, Norgine, Daiichi-Sankyo, Novartis, Sanofi, Consilient, and Pharmasure have been named in advertisements for breaches of the ABPI Code

    02 August 2021

    read more
  • GUIDELINES ON COMPANY PROCEDURES RELATING TO THE 2021 ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY

    07 July 2021

    read more